KOD - コディアック・サイエンシズ （Kodiak Sciences Inc）KODのニュース
Kodiak Sciences files for $350M mixed securities offering 2023/05/15 21:40:32 Seeking Alpha
Kodiak Sciences (KOD) has filed for a $350M mixed shelf securities offering. Read more here.
Kodiak Sciences Inc. Files $350M Mixed Shelf 2023/05/15 21:17:01 Investing.com
https://www.investing.com/news/assorted/kodiak-sciences-inc-files-350m-mixed-shelf-432SI-3083002
Kodiak Sciences GAAP EPS of -$1.35 2023/05/15 20:57:03 Seeking Alpha
Kodiak Sciences press release (KOD): Q1 GAAP EPS of -$1.35.Kodiak ended the first quarter of 2023 with $421.2 million of cash, cash equivalents and marketable securities.
Kodiak Sciences (KOD) Investor Presentation - Slideshow 2023/04/04 17:37:38 Seeking Alpha
The following slide deck was published by Kodiak Sciences Inc.
Kodiak, Arcturus top healthcare gainers; ProQR, Sharecare among losers 2023/03/29 14:05:07 Seeking Alpha
Kodiak Sciences (KOD) +19%. Arcturus Therapeutics (ARCT) +16%. ProQR Therapeutics (PRQR) -31%. Sharecare (SHCR) -29%.
Kodiak Sciences (KOD): A Chance To Change The Narrative 2023/02/08 14:55:43 Seeking Alpha
Kodiak stock was crushed last Feb. when its lead developmental asset failed to meet its primary end point. Check out if KOD stock is now worthy of a small bet.
Thinking Of Investing In Kodiak Sciences Inc. (NASDAQ: KOD) Stock? Read This First 2022/12/31 20:00:00 Stocks Register
Kodiak Sciences Inc. (NASDAQ:KOD) shares, rose in value on Friday, 12/30/22, with the stock price up by 4.22% to the previous day’s close as strong demand from buyers drove the stock to $7.16. Actively observing the price movement in the last trading, the stock closed the session at $6.87, falling within a range of $6.68 … Thinking Of Investing In Kodiak Sciences Inc. (NASDAQ: KOD) Stock? Read This First Read More »
CapitalOne Starts Kodiak Sciences Inc. at Overweight 2022/11/15 13:49:04 Investing.com
https://www.investing.com/news/pro/capitalone-starts-kodiak-sciences-inc-at-overweight-432SI-2944700
Kodiak: Turnaround Strategy Has Shown Life Thus Far (NASDAQ:KOD) 2022/11/14 18:17:47 Seeking Alpha
Primary endpoint of phase 3 BEACON study, using tarcocimab tedromer for the treatment of patients with macular edema due to retinal vein occlusion, was met. Read the outlook here.
Kodiak Sciences Inc. (KOD) is an excellent investment, but the stock is overvalued/undervalued right now 2022/11/11 12:24:00 US Post News
The share price of Kodiak Sciences Inc. (NASDAQ:KOD) rose to $7.12 per share on Thursday from $6.73. While Kodiak Sciences Inc. has overperformed by 5.79%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, KOD fell by -93.63%, with highs and lows ranging from $116.78 to $4.90, […]
CapitalOne Starts Kodiak Sciences Inc. at Overweight 2022/11/15 13:49:04 Investing.com
https://www.investing.com/news/pro/capitalone-starts-kodiak-sciences-inc-at-overweight-432SI-2944700
Kodiak: Turnaround Strategy Has Shown Life Thus Far (NASDAQ:KOD) 2022/11/14 18:17:47 Seeking Alpha
Primary endpoint of phase 3 BEACON study, using tarcocimab tedromer for the treatment of patients with macular edema due to retinal vein occlusion, was met. Read the outlook here.
Kodiak Sciences Inc. (KOD) is an excellent investment, but the stock is overvalued/undervalued right now 2022/11/11 12:24:00 US Post News
The share price of Kodiak Sciences Inc. (NASDAQ:KOD) rose to $7.12 per share on Thursday from $6.73. While Kodiak Sciences Inc. has overperformed by 5.79%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, KOD fell by -93.63%, with highs and lows ranging from $116.78 to $4.90, […]